Dotz Nano Limited Appoints Sharon Malka as Chief Executive Officer
innovative drug through world-wide regulatory approvals and led its global commercialization strategy via multiple distribution channels and collaborations, becoming the new standard-of-care. In addition, he established a certified pharmaceutical manufacturing capacity to support a global commercial launch. In doing so acquired an intimate understanding of technology development roadmaps and commercialisation pathways. Prior to that, Mr. Malka was a partner at Variance Economic Consulting Ltd., a multi-disciplinary consulting boutique, specialising in financial services for international and local Hi-Tech clients. Mr. Malka also served as a Senior Manager at PricewaterhouseCoopers Corporate Finance, where he gained extensive experience in company valuations, joint ventures and financial instruments for investments, M&A, and IPOs. Mr. Malka is a certified CPA and holds a B.Sc. in Business Administration from the Business Management College in Israel and an M.B.A. from Bar Ilan University, Israel.